Ultrasound-guided autologous blood injection in patients with chronic recurrent temporomandibular joint dislocation.
Natl J Maxillofac Surg
; 11(1): 34-39, 2020.
Article
in En
| MEDLINE
| ID: mdl-33041574
ABSTRACT
OBJECTIVE:
To evaluate the accuracy and effectiveness of ultrasound (US) guided autologous blood injection (ABI) for the treatment of chronic recurrent TMJ dislocation.DESIGN:
Prospective cohort study.SETTING:
Centre for medical education and research. PARTICIPANTS OR ANIMALS SPECIMENS CADAVERS Ninteen patients with chronic recurrent TMJ dislocation (Fifteen bilateral and fourteen unilateral).INTERVENTIONS:
Autologous blood injected, 2ml in superior joint space (SJS) and 1 ml in peri-capsular tissue (PT) under ultra sound guidance. MAIN OUTCOMEMEASURES:
Reduction in number of dislocation episodes, maximal mouth opening, pain (visual analogue scale) and TMJ sounds (present or absent) at the end of 2 weeks, 3 months, 6 months and 1 year.RESULTS:
At 2 weeks post operatively 18 patients (95%) were asymptomatic only one patient (5%) complained of Recurrence of dislocation and was treated successfully by a 2nd injection. At subsequent follow up visits none reported dislocation.CONCLUSIONS:
US guided ABI for patients with chronic recurrent TMJ dislocations serves as an alternative, minimally invasive, highly effective and accurate modality of treatment since it includes exposure without radiation, real-time visualization of soft tissues, visualization of the needle tip advancement, local anesthetic spread relevant to the surrounding structures which can be performed on an outpatient basis.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
/
Observational_studies
Language:
En
Journal:
Natl J Maxillofac Surg
Year:
2020
Document type:
Article
Affiliation country:
India